127510-96-7 Usage
Description
Methyl 2-cyano-4-fluorobenzoate is a chemical compound characterized by the presence of a methyl group, a cyano group, and a fluorine atom attached to a benzoate ring. It is recognized for its versatile reactivity and is widely utilized in organic synthesis, particularly as a building block for the development of pharmaceuticals and agrochemicals.
Uses
Used in Pharmaceutical Industry:
Methyl 2-cyano-4-fluorobenzoate is used as a key intermediate in the synthesis of various pharmaceuticals. Its unique structure allows for the creation of diverse drug molecules with potential therapeutic applications.
Used in Agrochemical Industry:
In the agrochemical sector, Methyl 2-cyano-4-fluorobenzoate serves as a crucial building block for the development of new agrochemicals, such as pesticides and herbicides, aimed at enhancing crop protection and yield.
Used as a Reagent in Organic Synthesis:
Methyl 2-cyano-4-fluorobenzoate is employed as a reagent in the preparation of heterocycles, which are important structural motifs in many biologically active compounds and have applications in various fields, including medicine and materials science.
Used in the Production of Other Organic Compounds:
As an intermediate, Methyl 2-cyano-4-fluorobenzoate is involved in the synthesis of a range of other organic compounds, contributing to the advancement of organic chemistry and the discovery of new chemical entities with potential applications across various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 127510-96-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,7,5,1 and 0 respectively; the second part has 2 digits, 9 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 127510-96:
(8*1)+(7*2)+(6*7)+(5*5)+(4*1)+(3*0)+(2*9)+(1*6)=117
117 % 10 = 7
So 127510-96-7 is a valid CAS Registry Number.
127510-96-7Relevant articles and documents
HORMONE RECEPTOR MODULATORS FOR TREATING METABOLIC CONDITIONS AND DISORDERS
-
, (2018/03/25)
The invention relates to activators of FXR useful in the treatment of autoimmune disorders, liver disease, intestinal disease, kidney disease, cancer, and other diseases in which FXR plays a role, having the Formula (I): (I), wherein L1, A, X1, X2, R1, R2, and R3 are described herein.
PYRIDINONES/PYRAZINONES, METHOD OF MAKING, AND METHOD OF USE THEREOF
-
Page/Page column 113-114, (2012/03/26)
Pyridone and pyrazinone compounds of Formula (I) including stereoisomers, tautomers, and pharmaceutically acceptable salts thereof, useful for inhibiting Btk kinase, and for treating immune disorders such as inflammation mediated by Btk kinase. Methods of using compounds of Formula I for in vitro, in situ, and in vivo diagnosis, and treatment of such disorders in mammalian cells, or associated pathological conditions, are disclosed.
NEW 5,6-DIHYDROPYRIN-2-ONE COMPOUNDS USEFUL AS INHIBITORS OF THROMBIN
-
Page/Page column 100, (2010/02/12)
There is provided a compound of formula (I) wherein R1, R2a, R2b, R3a, R3b, R4, R5, R6, A, G and L have meanings given in the description, which compounds are useful a
